These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 2438365

  • 1. Localization of epidermal growth factor receptors in the human prostate by biochemical and immunocytochemical methods.
    Maddy SQ, Chisholm GD, Hawkins RA, Habib FK.
    J Endocrinol; 1987 Apr; 113(1):147-53. PubMed ID: 2438365
    [Abstract] [Full Text] [Related]

  • 2. Epidermal growth factor binding and steroid receptor content in human benign prostatic hyperplasia.
    Lubrano C, Petrangeli E, Catizone A, Santonati A, Concolino G, Rombolá N, Frati L, Di Silverio F, Sciarra F.
    J Steroid Biochem; 1989 Apr; 34(1-6):499-504. PubMed ID: 2483222
    [Abstract] [Full Text] [Related]

  • 3. Localization and characterization of epidermal growth factor receptors on human testicular tissue by biochemical and immunohistochemical techniques.
    Stubbs SC, Hargreave TB, Habib FK.
    J Endocrinol; 1990 Jun; 125(3):485-92. PubMed ID: 2373986
    [Abstract] [Full Text] [Related]

  • 4. Epidermal growth factor receptors in human prostate cancer: correlation with histological differentiation of the tumour.
    Maddy SQ, Chisholm GD, Busuttil A, Habib FK.
    Br J Cancer; 1989 Jul; 60(1):41-4. PubMed ID: 2478180
    [Abstract] [Full Text] [Related]

  • 5. Receptors for luteinizing hormone-releasing hormone, somatostatin, prolactin, and epidermal growth factor in rat and human prostate cancers and in benign prostate hyperplasia.
    Fekete M, Redding TW, Comaru-Schally AM, Pontes JE, Connelly RW, Srkalovic G, Schally AV.
    Prostate; 1989 Jul; 14(3):191-208. PubMed ID: 2471961
    [Abstract] [Full Text] [Related]

  • 6. Epidermal growth factor receptors in human hyperplastic prostate tissue and their modulation by chronic treatment with a gonadotropin-releasing hormone analog.
    Fiorelli G, De Bellis A, Longo A, Natali A, Costantini A, Serio M.
    J Clin Endocrinol Metab; 1989 Apr; 68(4):740-3. PubMed ID: 2466042
    [Abstract] [Full Text] [Related]

  • 7. Immunohistochemical localization of transforming growth factor-alpha, epidermal growth factor receptor and c-erbB-2 protein in hyperplastic human prostates.
    Giri DK, Pal R, Wadhwa SN, Talwar GP.
    Carcinogenesis; 1995 Apr; 16(4):729-33. PubMed ID: 7537180
    [Abstract] [Full Text] [Related]

  • 8. Characterization of the prolactin receptor in human prostate.
    Leake A, Chisholm GD, Habib FK.
    J Endocrinol; 1983 Nov; 99(2):321-8. PubMed ID: 6197504
    [Abstract] [Full Text] [Related]

  • 9. Relationship between epidermal growth factor and its receptor in human benign prostatic hyperplasia.
    Lubrano C, Toscano V, Petrangeli E, Spera G, Trotta MC, Rombolà N, Frati L, Di Silverio F, Sciarra F.
    J Steroid Biochem Mol Biol; 1993 Oct; 46(4):463-8. PubMed ID: 7692939
    [Abstract] [Full Text] [Related]

  • 10. Growth factor receptors and oncogene expression in prostate cells.
    Davies P, Eaton CL, France TD, Phillips ME.
    Am J Clin Oncol; 1988 Oct; 11 Suppl 2():S1-7. PubMed ID: 2468269
    [Abstract] [Full Text] [Related]

  • 11. Specific binding sites for 125I-labelled epidermal growth factor in the ovine corpus luteum and human placenta.
    Bramley TA, Menzies GS.
    J Endocrinol; 1992 Oct; 135(1):5-16. PubMed ID: 1431682
    [Abstract] [Full Text] [Related]

  • 12. Binding of epidermal growth factor by human normal, hypertrophic, and carcinomatous prostate.
    Davies P, Eaton CL.
    Prostate; 1989 Oct; 14(2):123-32. PubMed ID: 2469072
    [Abstract] [Full Text] [Related]

  • 13. Growth factors in the human prostate.
    Fiorelli G, De Bellis A, Longo A, Pioli P, Costantini A, Giannini S, Forti G, Serio M.
    J Steroid Biochem Mol Biol; 1991 Oct; 40(1-3):199-205. PubMed ID: 1958521
    [Abstract] [Full Text] [Related]

  • 14. Radioligand binding assay of epidermal growth factor receptor: causes of variability and standardization of the assay.
    Dittadi R, Gion M, Brazzale A, Bruscagnin G.
    Clin Chem; 1990 Jun; 36(6):849-54. PubMed ID: 2357821
    [Abstract] [Full Text] [Related]

  • 15. Immunohistochemical comparative analysis of transforming growth factor alpha, epidermal growth factor, and epidermal growth factor receptor in normal, hyperplastic and neoplastic human prostates.
    De Miguel P, Royuela, Bethencourt R, Ruiz A, Fraile B, Paniagua R.
    Cytokine; 1999 Sep; 11(9):722-7. PubMed ID: 10479409
    [Abstract] [Full Text] [Related]

  • 16. Epidermal growth factor is not the major growth-promoting agent in extracts of prostatic tissue.
    Story MT, Jacobs SC, Lawson RK.
    J Urol; 1983 Jul; 130(1):175-9. PubMed ID: 6191046
    [Abstract] [Full Text] [Related]

  • 17. Insulin-like growth factor-I receptors in human hyperplastic prostate tissue: characterization, tissue localization, and their modulation by chronic treatment with a gonadotropin-releasing hormone analog.
    Fiorelli G, De Bellis A, Longo A, Giannini S, Natali A, Costantini A, Vannelli GB, Serio M.
    J Clin Endocrinol Metab; 1991 Apr; 72(4):740-6. PubMed ID: 1848565
    [Abstract] [Full Text] [Related]

  • 18. Prolactin and luteinizing hormone-releasing hormone receptors in human benign prostatic hyperplasia and prostate cancer.
    Kadar T, Ben-David M, Pontes JE, Fekete M, Schally AV.
    Prostate; 1988 Apr; 12(4):299-307. PubMed ID: 2455886
    [Abstract] [Full Text] [Related]

  • 19. Sex steroids and epidermal growth factor in benign prostatic hyperplasia (BPH).
    Sciarra F.
    Ann N Y Acad Sci; 1995 Jun 12; 761():66-78. PubMed ID: 7542859
    [Abstract] [Full Text] [Related]

  • 20. Expression of transforming growth factor-alpha, epidermal growth factor and the epidermal growth factor receptor in adenocarcinoma of the prostate and benign prostatic hyperplasia.
    Myers RB, Kudlow JE, Grizzle WE.
    Mod Pathol; 1993 Nov 12; 6(6):733-7. PubMed ID: 7508115
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.